.jpg)
The DeepSense Team
Get to Know Us
![th[8].jpg](https://static.wixstatic.com/media/ccdd0b_2291e2d0875144e48305023d971d5127~mv2.jpg/v1/crop/x_0,y_57,w_376,h_261/fill/w_460,h_320,al_c,lg_1,q_80,enc_auto/th%5B8%5D.jpg)
Johan Brag
Chief Executive Officer
Victoria Vertesi
Chief Operating Officer
Shiming Li
Chief Scientific Officer
![th[3].jpg](https://static.wixstatic.com/media/ccdd0b_67ca2043323c4f768e6652778c9ca72a~mv2.jpg/v1/crop/x_0,y_12,w_370,h_257/fill/w_460,h_320,al_c,lg_1,q_80,enc_auto/th%5B3%5D.jpg)
Brad Higgins
Chairman
Jasmina Jankicevic
Chief Medical Officer
If you want to learn more about our amazing team members, get in touch.
About Us
A Revolution in Inflammation Drug Development
By combining the latest advances in biotechnology, organic chemistry and artificial intelligence we strive to find novel therapeutics which can enhance our innate immune system to better fight off diseases.
A new opportunity for researchers and patients alike is drugs that target the innate immune system – our body’s first line of defense and the primary instigator of inflammation. The innate immune response relies on pattern-recognition receptors (PRRs) to detect pathogenic substances that may enter our bodies or form during tissue stress. “Inflammasomes” are newly identified PRRs that control the activation and release of powerful inflammation mediators. They are members of the IL-1beta family of cytokines and thus play an integral role in innate immunity.
